Matthew Strobeck, Director at BIODESIX INC (BDSX), bought 4,686,954 shares at $1.15 ($5.4M) on 2022-11-21, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 108,695 | $125K | 2.3% |
| 2 | $1.15 | 108,695 | $125K | 2.3% |
| 3 | $1.15 | 869,565 | $1000K | 18.6% |
| 4 | $1.15 | 869,565 | $1.0M | 18.6% |
| 5 | $1.15 | 1,365,217 | $1.6M | 29.1% |
| 6 | $1.15 | 1,365,217 |
| $1.6M |
| 29.1% |
| Total | $1.15 avg | 4,686,954 | $5.4M | 100% |
| Filing → |
| AZYO | BUY | 2023-02-13 | $398K | — | Filing → |
| BDSX | BUY | 2022-04-11 | $2.0M | — | Filing → |
| BDSX | BUY | 2022-01-04 | $643K | — | Filing → |